Varicose veins
Drug research and approvals for varicose veins: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.
As of Nov 21, 2026, 88 studies of varicose veins are recruiting on ClinicalTrials.gov, and Health Canada has authorized 0 drug trials for it since 2013.
- Recruiting worldwide: 88
- Trials authorized in Canada: 0
- FDA orphan approvals: 0
- EU medicines: 0
- The Value of Spleen Thickness and Spleen Diameter for Gastroesophageal Varices Diagnosis in Compensated CirrhosisNCT07920744 · Not reported · Fifth Affiliated Hospital, Sun Yat-Sen University · starts Oct 28, 2026
- Vacuum Compression Therapy and Tissue Oxygenation in Chronic Leg UlcersNCT07901517 · Not applicable · BTL Industries Ltd. · starts Oct 15, 2026
- Pilot Study: Evaluation of the Safety of the Application of Non-thermal HIFU for Varicose Veins Treatment of the Lower…NCT07878767 · Not applicable · VeinSound · starts Apr 22, 2026
- Subfascial Endoscopic Perforator Surgery (SEPS) Versus Open Ligation for Lower Limb Varicose VeinsNCT07872150 · Not applicable · King Edward Medical University · starts Jul 10, 2026
- EUS-Guided Coil and Glue vs Glue Injection for Bleeding Gastric Varices in CirrhosisNCT07855913 · Not applicable · Medanta, The Medicity, India · starts Sep 1, 2026
- A Prospective, Multicenter, Randomized Controlled Trial Investigating the Impact of Fasting Duration on Postoperative…NCT07774143 · Not applicable · The First Affiliated Hospital of Zhengzhou University · starts Jun 20, 2026
- Dose-Response Structured Calf Muscle Pump Activation Strategies Versus Unsupervised Home WalksNCT07763782 · Not applicable · MTI University · starts Oct 1, 2026
- Outcomes of Iliac Vein Stenting With Dedicated Venous Stents in Treatment of Chronic Post-thrombotic Venous UlcersNCT07762222 · Not applicable · Ain Shams University · starts Mar 2, 2025
- Noninvasive Artificial Venous Stasis for Reperfusion in STEMINCT07689591 · Not reported · Firat University · starts Aug 15, 2026
Approved 8
Phase 3 1
How its trials ended
247 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrongOf the 47 whose ending is known, 55% met their primary endpoint, 4% missed it and 40% stopped early.
- Completed, result not reported7832%
- Status unknown7832%
- Ongoing4418%
- Met its primary endpoint2611%
- Stopped: other or unclear146%
- Stopped: enrollment or feasibility42%
- Missed its primary endpoint21%
- Stopped: sponsor or business decision1<1%
Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA